Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends
Introduced
Moved
Reached a final decision
Became law
Derived from the official record below.
Officially: “AN ACT to amend Tennessee Code Annotated, Title 20 and Title 33, relative to opioids.” Read the full text
114th general assembly (2025-2026)
What it does
Opioids - As enacted, adds Alvogen, Inc., Apotex Corp., and Zydus Pharmaceuticals (USA) Inc. to the list of companies that may be released by the attorney general for pending or future claims regarding opioids. - Amends TCA Title 20 and Title 33. SB1495 has been assigned Public Chapter Number 888 by the Secretary of State.
From the official legislative record, shown verbatim. Not legal advice.
Where it is
Show all 40 actions
Filed for introduction · Jan 22, 2026
House
Intro., P1C. · Feb 2, 2026
House
P2C, ref. to Judiciary Committee · Feb 4, 2026
House
Assigned to s/c Civil Justice Subcommittee · Feb 4, 2026
House
Placed on s/c cal Civil Justice Subcommittee for 2/11/2026 · Feb 4, 2026
House
Action Def. in s/c Civil Justice Subcommittee to 2/18/2026 · Feb 11, 2026
House
Placed on s/c cal Civil Justice Subcommittee for 2/18/2026 · Feb 11, 2026
House
Rec. for pass by s/c ref. to Judiciary Committee · Feb 18, 2026
House
Placed on cal. Judiciary Committee for 3/4/2026 · Feb 25, 2026
House
Action def. in Judiciary Committee to 3/11/2026 · Mar 4, 2026
House
Placed on cal. Judiciary Committee for 3/11/2026 · Mar 4, 2026
House
Rec. for pass; ref to Finance, Ways, and Means Committee · Mar 11, 2026
House
Assigned to s/c Finance, Ways, and Means Subcommittee · Mar 11, 2026
House
Placed on s/c cal Finance, Ways, and Means Subcommittee for 4/1/2026 · Mar 25, 2026
House
Rec. for pass by s/c ref. to Finance, Ways, and Means Committee · Apr 1, 2026
House
Rec. for pass by s/c ref. to Finance, Ways, and Means Committee · Apr 1, 2026
House
Placed on cal. Finance, Ways, and Means Committee for 4/7/2026 · Apr 1, 2026
House
Rec. for pass; ref to Calendar & Rules Committee · Apr 7, 2026
House
Placed on cal. Calendar & Rules Committee for 4/9/2026 · Apr 8, 2026
House
H. Placed on Consent Calendar for 4/13/2026 · Apr 9, 2026
House
Objected to on Consent Calendar. · Apr 13, 2026
House
H. Placed on Regular Calendar for 4/14/2026 · Apr 13, 2026
House
Comp. SB subst. · Apr 16, 2026
House
Comp. became Pub. Ch. 888 · May 18, 2026
Senate
Filed for introduction · Dec 23, 2025
Senate
Introduced, Passed on First Consideration · Jan 13, 2026
Senate
Passed on Second Consideration, refer to Senate Judiciary Committee · Jan 14, 2026
Senate
Placed on Senate Judiciary Committee calendar for 2/10/2026 · Feb 3, 2026
Senate
Recommended for passage, refer to Senate Calendar Committee · Feb 10, 2026
Senate
Placed on Senate Consent Calendar 2 for 2/19/2026 · Feb 17, 2026
Senate
Passed Senate, Ayes 31, Nays 0 · Feb 19, 2026
Senate
Engrossed; ready for transmission to House · Feb 19, 2026
Senate
Rcvd. from S., held on H. desk. · Feb 23, 2026
House
Subst. for comp. HB. · Apr 16, 2026
House
Passed H., Ayes 87, Nays 0, PNV 1 · Apr 16, 2026
House
Enrolled and ready for signatures · Apr 20, 2026
Senate
Signed by Senate Speaker · Apr 21, 2026
Senate
Signed by H. Speaker · Apr 21, 2026
House
Transmitted to Governor for action. · Apr 23, 2026
Senate
Signed by Governor. · May 5, 2026
Senate
The numbers
1
sponsor on the bill
Sponsors
Recorded votes
REGULAR CALENDAR PASSAGE ON THIRD CONSIDERATIONHouse · 2026-04-16 · Passed · Ayes 87, Noes 0, Present and not voting 1
Motion to AdoptSenate · 2026-02-19 · Passed · Ayes 31, Noes 0
Recommended for passage, refer to Senate Calendar CommitteeSenate · 2026-02-10 · Passed · Ayes 8, Noes 0
Roll-call results shown verbatim from the Tennessee legislature’s records. A result reflects that roll call’s own motion, not the bill’s overall outcome.
Every fact on this page links to its source, starting with the official bill record. Last action: Signed by Governor. (May 5, 2026).